Evidence map›Paper›PMID 41080439›Full record

ArticleFrontiers in epidemiology2025

Sex- and age-specific differences in excess mortality in China during the COVID-19 pandemic: a study based on official vital statistics data.

Yao Li

Abstract read
In one paragraph

Article in Frontiers in epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yao LiCriDIS, Department of Sociology, Catholic University of Louvain, Louvain-la-neuve, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to investigate the excess mortality observed in China between 2020 and 2023 and its underlying causes, including the COVID-19 pandemic, sex ratio, and aging trends. Methods: We collected data regarding number of deaths and mortality rates of the years 2015-2019 from the China Statistical Yearbook of Population and Employment, and analyzed the data by age and sex. We created a standardized sex and age structure dataset and compared the excess mortality rates of different sexes and age groups for the years 2020 to 2023. Results: The sex-and age-specific number of deaths in all three years decreased compared to the number of deaths in the standardized sex and age structure dataset. The most significant decline was observed in 2021, whereas the number of deaths in 2022 and 2023 increased compared to that in 2021. It has been found that excess mortality is generally less prevalent among older age groups, and excess mortality rate tends to be lower among younger age groups. Additionally, in 2021, 2022, and 2023, the excess mortality rate was greater for men than for women, whereas it was greater for women in 2020. These differences can be attributed to various factors. Discussion: This is the first study to examine excess mortality in China during the COVID-19 pandemic using age- and sex-standardized data. These findings underscore the need for a deeper exploration of the effects of sex and age on health outcomes.

Indexed as

age-and sex-specific excess mortalityCOVID-19excess mortalityexcess mortality ratezero-COVID

Identifiers

PMID41080439
PMCPMC12507777

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.